Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
2(20%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_1
1
10%
Ph phase_3
5
50%
Ph phase_2
4
40%

Phase Distribution

1

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
5(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (10.0%)
Phase 24 (40.0%)
Phase 35 (50.0%)

Trials by Status

completed660%
unknown220%
recruiting220%

Recent Activity

2 active trials
Showing 5 of 10
recruitingphase_2

A Polypill for Acute Coronary Syndrome

NCT07032389
completedphase_2

Polypill Strategy for Heart Failure With Reduced Ejection Fraction

NCT04633005
recruitingphase_1

Polypill for Prevention of Cardiomyopathy

NCT06143566
completedphase_2

Polypill in Acute Coronary Syndrome

NCT05514938
unknownphase_3

Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants

NCT03459560
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07032389Phase 2

A Polypill for Acute Coronary Syndrome

Recruiting
NCT04633005Phase 2

Polypill Strategy for Heart Failure With Reduced Ejection Fraction

Completed
NCT06143566Phase 1

Polypill for Prevention of Cardiomyopathy

Recruiting
NCT05514938Phase 2

Polypill in Acute Coronary Syndrome

Completed
NCT03459560Phase 3

Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants

Unknown
NCT03541109Phase 3

A Polypill for Secondary Prevention of Ischemic Heart Disease

Unknown
NCT01245608Phase 3

Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.

Completed
NCT01271985Phase 3

Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill

Completed
NCT01057537Phase 3

UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events

Completed
NCT00603590Phase 2

Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease

Completed

All 10 trials loaded

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
10